T1	Participants 0 15	Dexmedetomidine
T2	Participants 363 370	METHODS
T3	Participants 1463 1471	pressure
T4	Participants 1542 1553	CONCLUSIONS
T5	Participants 715 723	received
T6	Participants 185 196	prospective
T7	Participants 102 111	injection
T8	Participants 1093 1094	.
T9	Participants 979 991	triglyceride
